New study investigates whether chemoradiation before surgery reduces cancer cells in the blood
NCT ID NCT07194616
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This clinical trial is looking at how chemoradiation given before surgery affects circulating tumor cells (CTCs) in patients with stage II-III rectal cancer. CTCs are cancer cells that travel in the blood and may indicate how likely the cancer is to spread. The study will compare two groups: one that gets chemoradiation followed by surgery, and another that has surgery alone. By tracking CTCs over time, researchers hope to learn more about which treatment approach might be better at controlling the disease.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- fluoropyrimidine-based chemotherapy and radiotherapy
- What this could lead to
- If successful, this study could help doctors understand whether chemoradiation before surgery reduces the spread of cancer cells in the bloodstream, potentially guiding better treatment decisions for rectal cancer.
- What could go wrong
- This is an early-stage observational trial focused on a biomarker, not a direct treatment outcome. The results may not lead to immediate changes in patient care, and the sample size is relatively small.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Municipal Hospital Ostrava - Fifejdy
RECRUITINGOstrava, 728 80, Czechia
-
Palacky University Olomouc, Faculty of Medicine
RECRUITINGOlomouc, Czechia
-
University Hospital Olomouc
RECRUITINGOlomouc, 779 00, Czechia
-
University Hospital Ostrava
RECRUITINGOstrava, 70852, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test and CT combo may spare rectal cancer patients a second surgery
- Radiation may spare early rectal cancer patients from radical surgery
- New drug cocktail aims to shrink rectal tumors and avoid colostomy
- Vaccinia virus targets rectal tumors in new immunotherapy combo
- New triple therapy aims to wipe out rectal cancer before surgery
- Robot vs. transanal surgery: which is better for low rectal cancer?